LEUKOERYTHROBLASTOSIS

LEUKOERYTHROBLASTOSIS was reported 100 times

LEUKOERYTHROBLASTOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Rifamycin Antimycobacterial [EPC] 2 0.0006
1 Thrombopoietin Receptor Agonist [EPC] 7 0.0005
2 Erythroid Maturation Agent [EPC] 1 0.0004
3 Sulfone [EPC] 4 0.0004
4 Topoisomerase Inhibitor [EPC] 23 0.0003
5 Antimalarial [EPC] 2 0.0002
6 Antiprotozoal [EPC] 2 0.0002
7 Alkylating Drug [EPC] 29 0.0001
8 Alkaloid [EPC] 3 0.0001
9 Folate Analog Metabolic Inhibitor [EPC] 46 0.0001
10 CD20-directed Cytolytic Antibody [EPC] 31 0.0001
11 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
12 Glycopeptide Antibacterial [EPC] 6 0.0001
13 Nitroimidazole Antimicrobial [EPC] 6 0.0001
14 Nucleoside Metabolic Inhibitor [EPC] 21 0.0001
15 Human Immunoglobulin G [EPC] 1 0.0000
16 Janus Kinase Inhibitor [EPC] 6 0.0000
17 Androgen [EPC] 1 0.0000
18 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
19 Iron Chelator [EPC] 1 0.0000
20 Androgen Receptor Inhibitor [EPC] 2 0.0000
21 Microtubule Inhibitor [EPC] 4 0.0000
22 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
23 Vitamin D [EPC] 6 0.0000
24 Azole Antifungal [EPC] 3 0.0000
25 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
26 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
27 Vitamin B12 [EPC] 6 0.0000
28 Opioid Agonist [EPC] 5 0.0000
29 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
30 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
31 BCL-2 Inhibitor [EPC] 1 0.0000
32 Corticosteroid [EPC] 19 0.0000
33 Vitamin C [EPC] 6 0.0000
34 Catecholamine [EPC] 1 0.0000
35 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
36 Factor Xa Inhibitor [EPC] 3 0.0000
37 Kinase Inhibitor [EPC] 6 0.0000
38 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
39 Purine Antimetabolite [EPC] 1 0.0000
40 Expectorant [EPC] 2 0.0000
41 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
42 Platelet Aggregation Inhibitor [EPC] 4 0.0000
43 Loop Diuretic [EPC] 3 0.0000
44 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
45 Estrogen [EPC] 1 0.0000
46 RANK Ligand Inhibitor [EPC] 1 0.0000
47 Platinum-based Drug [EPC] 1 0.0000
48 beta-Adrenergic Blocker [EPC] 1 0.0000
49 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
50 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
51 Thalidomide Analog [EPC] 1 0.0000
52 Benzodiazepine [EPC] 1 0.0000